Bienville Capital Management, LLC Amgen Inc Transaction History

Bienville Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $261,513 - $313,347	-1,502 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $2,667 - $3,126	-16 Reduced 1.05%	1,502 $277,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $20,980 - $23,650	-116 Reduced 7.1%	1,518 $288,000
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $291,505 - $340,280	1,634 New	1,634 $318,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $361,563 - $422,532	-2,134 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $24,980 - $27,911	148 Added 7.45%	2,134 $371,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $332,237 - $379,326	1,986	1,986 $370,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Bienville Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bienville Capital Management, LLC with notifications on news.